Found: 40
Select item for more details and to access through your institution.
Albumin-Binding and Conventional PSMA Ligands in Combination with <sup>161</sup>Tb: Biodistribution, Dosimetry, and Preclinical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1625, doi. 10.2967/jnumed.123.265524
- By:
- Publication type:
- Article
<sup>161</sup>Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of <sup>161</sup>Tb into the Clinic.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1138, doi. 10.2967/jnumed.122.265268
- By:
- Publication type:
- Article
A Thermal Sublimation Generator of 131m Xe.
- Published in:
- Instruments (2410-390X), 2022, v. 6, n. 4, p. 76, doi. 10.3390/instruments6040076
- By:
- Publication type:
- Article
Tying Up a Loose End: On the Role of the C‐Terminal CCHHRAG Fragment of the Metalloregulator CueR.
- Published in:
- ChemBioChem, 2022, v. 23, n. 16, p. 1, doi. 10.1002/cbic.202200290
- By:
- Publication type:
- Article
Room-Temperature 181 Ta(TiO 2): An e-γ TDPAC Study.
- Published in:
- Crystals (2073-4352), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/cryst12070946
- By:
- Publication type:
- Article
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 4, p. 1113, doi. 10.1007/s00259-021-05564-0
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
Effective Intratumoral Retention of [<sup>103</sup>Pd]AuPd Alloy Nanoparticles Embedded in Gel‐Forming Liquids Paves the Way for New Nanobrachytherapy.
- Published in:
- Advanced Healthcare Materials, 2021, v. 10, n. 10, p. 1, doi. 10.1002/adhm.202002009
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
Simultaneous Visualization of 161 Tb- and 177 Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 536, doi. 10.3390/pharmaceutics13040536
- By:
- Publication type:
- Article
First-in-Human Application of Terbium-161: A Feasibility Study Using <sup>161</sup>Tb-DOTATOC.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258376
- By:
- Publication type:
- Article
Specific Heat of Holmium in Gold and Silver at Low Temperatures.
- Published in:
- Journal of Low Temperature Physics, 2021, v. 202, n. 1/2, p. 106, doi. 10.1007/s10909-020-02531-1
- By:
- Publication type:
- Article
Thermal Neutron Relative Biological Effectiveness Factors for Boron Neutron Capture Therapy from In Vitro Irradiations.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 10, p. 2144, doi. 10.3390/cells9102144
- By:
- Publication type:
- Article
Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 1953, doi. 10.3390/cells9091953
- By:
- Publication type:
- Article
The electron affinity of astatine.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17599-2
- By:
- Publication type:
- Article
Flexibility of the CueR Metal Site Probed by Instantaneous Change of Element and Oxidation State from Ag<sup>I</sup> to Cd<sup>II</sup>.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 33, p. 7451, doi. 10.1002/chem.202000132
- By:
- Publication type:
- Article
High-resolution laser resonance ionization spectroscopy of 143-147Pm.
- Published in:
- European Physical Journal A -- Hadrons & Nuclei, 2020, v. 56, n. 2, p. 1, doi. 10.1140/epja/s10050-020-00061-8
- By:
- Publication type:
- Article
Alpha-PET for Prostate Cancer: Preclinical investigation using <sup>149</sup>Tb-PSMA-617.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54150-w
- By:
- Publication type:
- Article
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1919, doi. 10.1007/s00259-019-04345-0
- By:
- Publication type:
- Article
Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 8, p. 424, doi. 10.3390/pharmaceutics11080424
- By:
- Publication type:
- Article
Chemical Purification of Terbium-155 from Pseudo-Isobaric Impurities in a Mass Separated Source Produced at CERN.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47463-3
- By:
- Publication type:
- Article
Preclinical investigations and first-in-human application of <sup>152</sup>Tb-PSMA-617 for PET/CT imaging of prostate cancer.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0538-1
- By:
- Publication type:
- Article
Production and characterization of no-carrier-added <sup>161</sup>Tb as an alternative to the clinically-applied <sup>177</sup>Lu for radionuclide therapy.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41181-019-0063-6
- By:
- Publication type:
- Article
Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0524-7
- By:
- Publication type:
- Article
Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid.
- Published in:
- Contrast Media & Molecular Imaging, 2019, p. 1, doi. 10.1155/2019/3728563
- By:
- Publication type:
- Article
Application of Calorimetric Low-Temperature Detectors for the Investigation of Z-Yield Distributions of Fission Fragments.
- Published in:
- Journal of Low Temperature Physics, 2018, v. 193, n. 5/6, p. 1257, doi. 10.1007/s10909-018-1988-y
- By:
- Publication type:
- Article
Sc as useful β-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2017, v. 2, n. 1, p. 1, doi. 10.1186/s41181-017-0024-x
- By:
- Publication type:
- Article
Preclinical in vivo application of Tb-DOTANOC: a radiolanthanide for PET imaging.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0189-4
- By:
- Publication type:
- Article
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 10, p. 1907, doi. 10.1007/s00259-014-2798-3
- By:
- Publication type:
- Article
Promising Prospects for <sup>44</sup>Sc-/<sup>47</sup>Sc-Based Theragnostics: Application of <sup>47</sup>Sc for Radionuclide Tumor Therapy in Mice.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 10, p. 1658, doi. 10.2967/jnumed.114.141614
- By:
- Publication type:
- Article
Folate Receptor Targeted Alpha-Therapy Using Terbium-149.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 3, p. 353, doi. 10.3390/ph7030353
- By:
- Publication type:
- Article
THE NUCLEAR OPTION.
- Published in:
- Biologist, 2013, v. 60, n. 3, p. 20
- By:
- Publication type:
- Article
A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α and β<sup>--</sup>-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 12, p. 1951, doi. 10.2967/jnumed.112.107540
- By:
- Publication type:
- Article
Revised rates for the stellar triple-aprocess from measurement of<sup>12</sup>C nuclear resonances.
- Published in:
- 2005
- By:
- Publication type:
- Letter